gut microbiota metabolism of l-carnitine and cardiovascular risk

gut microbiota metabolism of l-carnitine and cardiovascular risk γ-Butyrobetaine Is a Proatherogenic Intermediate in Microbial to TMAO: Cell Metabolism Microbiota in Gut‐Heart Axis: Metabolites

Name: gut microbiota metabolism of l-carnitine and cardiovascular risk γ-Butyrobetaine Is a Proatherogenic Intermediate in Microbial to TMAO: Cell Metabolism Microbiota in Gut‐Heart Axis: Metabolites
Brand: lagence-mr.com
SKU: 37188006158
Price: 26.65 USD
Availability: InStock
Rating: 4.0756 (9 reviews)

Microbiota in GutHeart Axis: Metabolites and Mechanisms in Cardiovascular Disease PMC Role of gut microbiota and derived metabolites in cardiovascular diseases ScienceDirect Linking anaerobic gut bacteria and cardiovascular disease Nature Microbiology Recent advances in modulation of cardiovascular diseases by the gut microbiota Journal of Human Hypertension Frontiers Gut macrobiotic and its metabolic pathways modulate cardiovascular disease

SKU: 37188006158 · From lagence-mr.com

4.1

USD26.65 USD48.65

Pay in 4 interest-free payments of $6.66 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 21 - Sep 26

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] (90).Soerianto W

gut microbiota metabolism of l-carnitine and cardiovascular risk -Butyrobetaine Is a Proatherogenic Intermediate in Microbial to TMAO: Cell Metabolism Microbiota in GutHeart Axis: Metabolites

For example, deletion or pharmacological inhibition of NAMPT promotes a very sharp decline in muscle, but a more modest reduction in the liver [37,38,84]

Among various mediators, transforming growth factor- (TGF-) and MAPK pathways are key effectors that integrate redox signaling with fibrogenic gene expression